ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 82,866,357
- Share change
- +14,892,279
- Total reported value
- $292,847,531
- Put/Call ratio
- 0%
- Price per share
- $3.53
- Number of holders
- 114
- Value change
- +$51,266,770
- Number of buys
- 67
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP H0036K147:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
12%
|
15,666,731
|
$62,666,924 | — | 30 Sep 2025 | |
| TCG Crossover GP II, LLC |
13D/G
|
— |
9.2%
|
11,390,175
|
$42,143,648 | $0 | 27 Oct 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
4%
from 13D/G
|
8,135,651
|
$32,542,604 | — | 30 Sep 2025 | |
| Prosight Management, LP |
13D/G
13F
|
Company |
6.8%
|
8,477,338
|
$31,366,151 | +$4,743,267 | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company · ORBIMED CAPITAL LLC |
2.6%
from 13D/G
|
5,907,351
|
$23,629,404 | — | 30 Sep 2025 | |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
|
Oaktree Fund Administration, LLC |
4.1%
|
4,673,441
|
$18,693,764 | $0 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5%
from 13D/G
|
4,511,699
|
$18,046,796 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.9%
|
3,669,067
|
$14,676,268 | — | 30 Sep 2025 | |
| HPWH TH AG |
13D/G
|
Dr. Hans-Peter Wild |
9.6%
|
9,788,944
|
$14,291,858 | $0 | 15 May 2025 | |
| Hans Peter Wild |
3/4/5
|
10%+ Owner |
7.6%
|
9,788,944
|
$14,291,858 | — | 15 May 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.8%
|
2,266,289
|
$9,065,156 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,594,434
|
$6,377,736 | — | 30 Sep 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.1%
|
1,390,175
|
$5,560,700 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
1,361,290
|
$5,445,160 | — | 30 Sep 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
1%
|
1,325,848
|
$5,303,392 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,295,941
|
$5,183,764 | — | 30 Sep 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.9%
|
1,156,721
|
$4,626,884 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
862,934
|
$3,451,736 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.64%
|
820,715
|
$3,282,860 | — | 30 Sep 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
733,568
|
$2,934,272 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.55%
|
701,619
|
$2,806,476 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.54%
|
688,471
|
$2,753,884 | — | 30 Sep 2025 | |
| Vantage Consulting Group Inc |
13F
|
Company |
0.53%
|
682,998
|
$2,731,992 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.53%
|
682,529
|
$2,730,116 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.46%
|
593,954
|
$2,375,816 | — | 30 Sep 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.42%
|
544,261
|
$2,177,044 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.38%
|
487,868
|
$1,951,472 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.33%
|
417,567
|
$1,670,268 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
330,597
|
$1,322,388 | — | 30 Sep 2025 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
0.25%
|
326,766
|
$1,307,064 | — | 30 Sep 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.22%
|
283,286
|
$1,133,144 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
262,261
|
$1,049,044 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.19%
|
250,084
|
$1,000,336 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.18%
|
227,500
|
$906,000 | — | 30 Sep 2025 | |
| Peter Hug |
3/4/5
|
Director |
0.17%
|
220,500
|
$789,390 | — | 13 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
182,012
|
$728,048 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.14%
|
177,032
|
$708,128 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
174,943
|
$699,772 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.13%
|
171,230
|
$684,920 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
159,993
|
$639,972 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
158,694
|
$634,774 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
145,252
|
$581,008 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.1%
|
133,427
|
$533,708 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
130,460
|
$521,840 | — | 30 Sep 2025 | |
| Viviane Monges |
3/4/5
|
Director |
0.11%
|
144,043
|
$515,673 | — | 13 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.1%
|
122,081
|
$488,324 | — | 30 Sep 2025 | |
| Florida Trust Wealth Management Co |
13F
|
Company |
0.09%
|
113,000
|
$452,000 | — | 30 Sep 2025 | |
| Creative Planning |
13F
|
Company |
0.08%
|
106,651
|
$426,604 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
100,474
|
$401,896 | — | 30 Sep 2025 | |
| Wilmington Savings Fund Society, FSB |
13F
|
Company |
0.08%
|
100,000
|
$400,000 | — | 30 Sep 2025 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q4 2025
As of 31 Dec 2025,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,866,357 shares.
The largest 10 holders included
Redmile Group, LLC, TCG Crossover Management, LLC, Prosight Management, LP, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, BlackRock, Inc., Point72 Asset Management, L.P., MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
105
Q4 2025 holders
114
Holder diff
9
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.